Elucidating the specific pharmacological mechanism of action (MOA) of naturally taking place compounds could be hard. Whilst Tarselli et al. (60) developed the first de novo artificial pathway to conolidine and showcased this naturally happening compound effectively suppresses responses to both equally chemically induced and inflammation-derived pa